CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Dose Escalation Study of Intratumoral or Intravenous Herpes Simplex Virus-1 Mutant HSV1716 in Patients With Refractory Non-Central Nervous System (Non-CNS) Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00931931
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:58.414996+00:00
Published At: 2018-03-21T00:00:00+00:00
Record Updated At: 2018-03-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rhabdomyosarcoma", "Osteosarcoma", "Ewing Sarcoma", "Soft Tissue Sarcoma", "Neuroblastoma", "Wilms Tumor", "Malignant Peripheral Nerve Sheath Tumor", "Clival Chordoma", "Non-CNS Solid Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-03-21"
protocolSection.identificationModule.nctId: "NCT00931931"
protocolSection.identificationModule.officialTitle: "A Phase I Dose Escalation Study of Intratumoral or Intravenous Herpes Simplex Virus-1 Mutant HSV1716 in Patients With Refractory Non-Central Nervous System (Non-CNS) Solid Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.